PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Cash Flow from Financing Activities | ₹-422 Cr | ₹818 Cr | ₹794 Cr | ₹3,977 Cr |
What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-422 Cr |
Mar2023 | ₹818 Cr |
Mar2022 | ₹794 Cr |
Mar2021 | ₹3,977 Cr |
How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-422 Cr | Negative | |
Mar2023 | ₹818 Cr | 2.97 | |
Mar2022 | ₹794 Cr | -80.03 | |
Mar2021 | ₹3,977 Cr | - |
Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹26,610.6 Cr | -3.1% | -8.7% | 36.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -3.1% |
-8.7% |
36.3% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses